Wockhardt Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Low debt relative to equity (D/E 0.4x)
Concerns
- ✗Premium to sector peers (P/E 109x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
WOCKPHARMA · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.93% | 51.60% | 51.99% | 51.99% | 49.09% | 49.09% |
| FII | 4.18% | 5.49% | 5.94% | 6.70% | 6.54% | 6.82% |
| DII | 0.30% | 4.82% | 4.45% | 5.08% | 9.82% | 10.58% |
| Public | 40.59% | 38.06% | 37.62% | 36.21% | 34.54% | 33.50% |
| Govt | — | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% |
Corporate Events
Annual General Meeting
Annual General Meeting
Latest News
All news →Wockhardt announces 27th AGM via newspaper notice
*Wockhardt announces 27th AGM via newspaper notice.* The company published public notices in Lokmat and Business Standard on **July 3, 2026**, for its upcoming AGM. This is part of compliance under SEBI Listing Regulations. No financial or operational updates were disclosed. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Wockhardt shares may react to investor meet updates
*Wockhardt shares may react to investor meet updates.* The company shared the transcript of its recent Analyst/Institutional Investor Meet pursuant to SEBI listing regulations. No major financial announcements or strategic shifts were disclosed. **No material triggers** for immediate trading action noted. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹965 Cr ▲8.7% | ₹888 Cr ▲13.6% | ₹782 Cr ▲6.0% | ₹738 Cr ▼0.7% | ₹743 Cr ▲3.1% | ₹721 Cr ▼10.9% | ₹809 Cr ▲9.5% | ₹739 Cr |
| Op. Profit | ₹225 Cr ▲27.1% | ₹177 Cr ▼0.6% | ₹178 Cr ▲147.2% | ₹72 Cr ▲12.5% | ₹64 Cr ▼50.0% | ₹128 Cr ▲16.4% | ₹110 Cr ▲20.9% | ₹91 Cr |
| OPM | 23.0% ▲15.0% | 20.0% ▼13.0% | 23.0% ▲130.0% | 10.0% ▲11.1% | 9.0% ▼50.0% | 18.0% ▲28.6% | 14.0% ▲16.7% | 12.0% |
| Net Profit | ₹164 Cr ▲168.9% | ₹61 Cr ▼25.6% | ₹82 Cr ▲175.9% | ₹-108 Cr ▼140.0% | ₹-45 Cr ▼325.0% | ₹20 Cr ▲225.0% | ₹-16 Cr ▲0.0% | ₹-16 Cr |
| EPS (₹) | 10.22 ▲181.5% | 3.63 ▼24.4% | 4.8 ▲186.6% | -5.54 ▼259.7% | -1.54 ▼279.1% | 0.86 ▲160.1% | -1.43 ▼57.1% | -0.91 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.4K Cr ▲12.0% | ₹3.0K Cr ▲7.6% | ₹2.8K Cr ▲5.5% | ₹2.7K Cr ▼17.9% | ₹3.2K Cr ▲19.3% | ₹2.7K Cr ▼4.8% | ₹2.8K Cr ▼20.2% | ₹3.6K Cr ▼9.4% | ₹3.9K Cr ▼1.9% | ₹4.0K Cr |
| Expenses | ₹2.7K Cr ▲3.9% | ₹2.6K Cr ▼3.3% | ₹2.7K Cr ▲6.2% | ₹2.5K Cr ▼13.1% | ₹2.9K Cr ▲5.8% | ₹2.8K Cr ▲1.7% | ₹2.7K Cr ▼24.4% | ₹3.6K Cr ▼8.4% | ₹3.9K Cr ▼1.7% | ₹4.0K Cr |
| Op. Profit | ₹652 Cr ▲65.9% | ₹393 Cr ▲331.9% | ₹91 Cr ▼10.8% | ₹102 Cr ▼65.8% | ₹298 Cr ▲573.0% | ₹-63 Cr ▼152.9% | ₹119 Cr ▲413.2% | ₹-38 Cr ▼2000.0% | ₹2 Cr ▼84.6% | ₹13 Cr |
| OPM | 19.0% ▲46.2% | 13.0% ▲333.3% | 3.0% ▼25.0% | 4.0% ▼55.6% | 9.0% ▲550.0% | -2.0% ▼150.0% | 4.0% ▲500.0% | -1.0% | 0.0% | 0.0% |
| Other Income | ₹26 Cr ▼58.1% | ₹62 Cr ▲264.7% | ₹17 Cr ▲109.8% | ₹-173 Cr ▼6.1% | ₹-163 Cr ▼116.7% | ₹975 Cr ▲633.1% | ₹133 Cr ▲14.7% | ₹116 Cr ▲148.7% | ₹-238 Cr ▼308.8% | ₹114 Cr |
| Interest | ₹213 Cr ▼16.1% | ₹254 Cr ▼16.7% | ₹305 Cr ▲1.0% | ₹302 Cr ▲1.0% | ₹299 Cr ▲20.1% | ₹249 Cr ▼9.8% | ₹276 Cr ▲4.2% | ₹265 Cr ▲3.9% | ₹255 Cr ▲13.3% | ₹225 Cr |
| Depreciation | ₹227 Cr ▲4.6% | ₹217 Cr ▼2.7% | ₹223 Cr ▼11.2% | ₹251 Cr ▲1.6% | ₹247 Cr ▲0.4% | ₹246 Cr ▲9.8% | ₹224 Cr ▲36.6% | ₹164 Cr ▲9.3% | ₹150 Cr ▲0.7% | ₹149 Cr |
| PBT | ₹238 Cr ▲1587.5% | ₹-16 Cr ▲96.2% | ₹-420 Cr ▲32.7% | ₹-624 Cr ▼51.8% | ₹-411 Cr ▼198.6% | ₹417 Cr ▲268.8% | ₹-247 Cr ▲29.6% | ₹-351 Cr ▲45.2% | ₹-641 Cr ▼159.5% | ₹-247 Cr |
| Tax % | 16.0% ▼93.8% | 256.0% ▲2033.3% | 12.0% | 0.0% ▲100.0% | -32.0% ▲50.8% | -65.0% ▲20.7% | -82.0% ▼115.8% | -38.0% ▼1050.0% | 4.0% ▲144.4% | -9.0% |
| Net Profit | ₹199 Cr ▲449.1% | ₹-57 Cr ▲87.9% | ₹-472 Cr ▲24.0% | ₹-621 Cr ▼122.6% | ₹-279 Cr ▼140.6% | ₹688 Cr ▲1700.0% | ₹-43 Cr ▲80.2% | ₹-217 Cr ▲67.5% | ₹-667 Cr ▼195.1% | ₹-226 Cr |
| EPS (₹) | 13.11 ▲553.6% | -2.89 ▲90.4% | -30.18 ▲22.2% | -38.8 ▼129.0% | -16.94 ▼135.6% | 47.64 ▲1090.4% | -4.81 ▲64.4% | -13.52 ▲68.0% | -42.3 ▼210.6% | -13.62 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% ▲100.0% | -56.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹81 Cr ▲0.0% | ₹81 Cr ▲5.2% | ₹77 Cr ▲6.9% | ₹72 Cr ▲0.0% | ₹72 Cr ▲30.9% | ₹55 Cr ▲0.0% | ₹55 Cr ▲0.0% | ₹55 Cr ▲0.0% | ₹55 Cr ▲0.0% | ₹55 Cr |
| Reserves | ₹4.9K Cr ▲13.7% | ₹4.3K Cr ▲30.2% | ₹3.3K Cr ▲0.0% | ₹3.3K Cr ▼13.1% | ₹3.8K Cr ▲13.7% | ₹3.3K Cr ▲26.9% | ₹2.6K Cr ▼0.1% | ₹2.6K Cr ▼6.4% | ₹2.8K Cr ▼14.8% | ₹3.3K Cr |
| Borrowings | ₹2.2K Cr ▲10.5% | ₹2.0K Cr ▼14.2% | ₹2.4K Cr ▲7.9% | ₹2.2K Cr ▼0.6% | ₹2.2K Cr ▼17.8% | ₹2.7K Cr ▼25.3% | ₹3.6K Cr ▲6.1% | ₹3.4K Cr ▼10.0% | ₹3.7K Cr ▼9.9% | ₹4.2K Cr |
| Other Liabilities | ₹1.4K Cr ▼16.5% | ₹1.7K Cr ▼9.1% | ₹1.9K Cr ▼10.1% | ₹2.1K Cr ▼2.5% | ₹2.2K Cr ▲27.8% | ₹1.7K Cr ▼10.5% | ₹1.9K Cr ▲7.4% | ₹1.8K Cr ▲15.4% | ₹1.5K Cr ▲2.8% | ₹1.5K Cr |
| Total Liabilities | ₹8.6K Cr ▲6.4% | ₹8.1K Cr ▲6.4% | ₹7.6K Cr ▼0.5% | ₹7.7K Cr ▼6.9% | ₹8.2K Cr ▲6.1% | ₹7.7K Cr ▼4.9% | ₹8.1K Cr ▲4.3% | ₹7.8K Cr ▼3.9% | ₹8.1K Cr ▼9.5% | ₹9.0K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹4.5K Cr ▲64.4% | ₹2.7K Cr ▼5.0% | ₹2.9K Cr ▼5.3% | ₹3.0K Cr ▼12.1% | ₹3.5K Cr ▲3.6% | ₹3.3K Cr ▼4.5% | ₹3.5K Cr ▲14.5% | ₹3.1K Cr ▲5.9% | ₹2.9K Cr ▲4.1% | ₹2.8K Cr |
| CWIP | ₹671 Cr ▼67.0% | ₹2.0K Cr ▲18.1% | ₹1.7K Cr ▲11.9% | ₹1.5K Cr ▲14.7% | ₹1.3K Cr ▼2.7% | ₹1.4K Cr ▼13.0% | ₹1.6K Cr ▲9.7% | ₹1.4K Cr ▲0.8% | ₹1.4K Cr ▲15.2% | ₹1.2K Cr |
| Investments | ₹412 Cr ▼2.4% | ₹422 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹214 Cr ▼62.0% | ₹563 Cr |
| Other Assets | ₹3.0K Cr ▲4.3% | ₹2.9K Cr ▼3.4% | ₹3.0K Cr ▼1.9% | ₹3.1K Cr ▼10.0% | ₹3.4K Cr ▲12.8% | ₹3.0K Cr ▼1.2% | ₹3.1K Cr ▼7.5% | ₹3.3K Cr ▼7.9% | ₹3.6K Cr ▼18.4% | ₹4.4K Cr |
| Total Assets | ₹8.6K Cr ▲6.4% | ₹8.1K Cr ▲6.4% | ₹7.6K Cr ▼0.5% | ₹7.7K Cr ▼6.9% | ₹8.2K Cr ▲6.1% | ₹7.7K Cr ▼4.9% | ₹8.1K Cr ▲4.3% | ₹7.8K Cr ▼3.9% | ₹8.1K Cr ▼9.5% | ₹9.0K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹390 Cr ▲1872.7% | ₹-22 Cr ▼110.0% | ₹219 Cr ▲43.1% | ₹153 Cr ▼63.0% | ₹413 Cr ▲243.9% | ₹-287 Cr ▼144.2% | ₹649 Cr ▲254.6% | ₹183 Cr ▲169.1% | ₹68 Cr ▲125.3% | ₹-269 Cr |
| Investing CF | ₹-241 Cr ▲69.1% | ₹-780 Cr ▼465.2% | ₹-138 Cr ▼16.9% | ₹-118 Cr ▲42.2% | ₹-204 Cr ▼113.9% | ₹1.5K Cr ▲1100.7% | ₹-147 Cr ▼258.1% | ₹93 Cr ▼85.4% | ₹635 Cr ▲192.8% | ₹-684 Cr |
| Financing CF | ₹-54 Cr ▼113.2% | ₹409 Cr ▲22.5% | ₹334 Cr ▲206.0% | ₹-315 Cr ▼343.7% | ₹-71 Cr ▲93.9% | ₹-1.2K Cr ▼72.2% | ₹-680 Cr ▲12.4% | ₹-776 Cr ▼0.9% | ₹-769 Cr ▼161.3% | ₹1.3K Cr |
| Net Cash Flow | ₹95 Cr ▲124.2% | ₹-393 Cr ▼194.7% | ₹415 Cr ▲248.2% | ₹-280 Cr ▼302.9% | ₹138 Cr ▲961.5% | ₹13 Cr ▲107.3% | ₹-178 Cr ▲64.4% | ₹-500 Cr ▼657.6% | ₹-66 Cr ▼121.9% | ₹301 Cr |
| Free Cash Flow | ₹76 Cr ▲120.2% | ₹-377 Cr ▼646.4% | ₹69 Cr ▲200.0% | ₹23 Cr ▼88.6% | ₹202 Cr ▲144.7% | ₹-452 Cr ▼193.0% | ₹486 Cr ▲282.7% | ₹127 Cr ▲153.4% | ₹-238 Cr ▲64.9% | ₹-678 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64d ▼20.0% | 80d ▼1.2% | 81d ▼26.4% | 110d ▲5.8% | 104d ▼16.1% | 124d ▼22.0% | 159d ▲22.3% | 130d ▲46.1% | 89d ▼5.3% | 94d |
| Inventory Days | 286d ▲22.2% | 234d ▲16.4% | 201d ▼6.9% | 216d ▼2.7% | 222d ▼13.3% | 256d ▲22.5% | 209d ▲14.2% | 183d ▲5.2% | 174d ▼28.4% | 243d |
| Days Payable | 182d ▼4.7% | 191d ▼20.4% | 240d ▼15.8% | 285d ▲7.5% | 265d ▲18.8% | 223d ▼18.0% | 272d ▲45.5% | 187d ▲53.3% | 122d ▲4.3% | 117d |
| Cash Conv. Cycle | 168d ▲36.6% | 123d ▲200.0% | 41d ▲0.0% | 41d ▼31.7% | 60d ▼61.8% | 157d ▲61.9% | 97d ▼23.0% | 126d ▼10.6% | 141d ▼35.9% | 220d |
| Working Capital Days | 89d ▲487.0% | -23d ▲85.9% | -163d ▲12.4% | -186d ▼60.3% | -116d ▲12.8% | -133d ▲22.2% | -171d ▼235.3% | -51d ▲8.9% | -56d ▼255.6% | 36d |
| ROCE | 8.0% ▲100.0% | 4.0% ▲500.0% | -1.0% | 0.0% ▼100.0% | 1.0% ▲133.3% | -3.0% ▼200.0% | -1.0% ▲0.0% | -1.0% ▲0.0% | -1.0% ▲0.0% | -1.0% |
Source: Screener.in · Lower days = better efficiency